The dual role of iNOS in cancer F Vannini, K Kashfi, N Nath Redox biology 6, 334-343, 2015 | 555 | 2015 |
Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras K Kashfi, KR Olson Biochemical pharmacology 85 (5), 689-703, 2013 | 347 | 2013 |
A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin S Gheibi, K Kashfi, A Ghasemi Biomedicine & pharmacotherapy 95, 605-613, 2017 | 313 | 2017 |
Nitric-oxide-donating NSAIDs as agents for cancer prevention B Rigas, K Kashfi Trends in Molecular Medicine 10 (7), 324-330, 2004 | 205 | 2004 |
Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect K Kashfi, Y Rayyan, LL Qiao, JL Williams, J Chen, P Del Soldato, ... Journal of Pharmacology and Experimental Therapeutics 303 (3), 1273-1282, 2002 | 204 | 2002 |
NOSH-Aspirin: A novel nitric oxide–hydrogen sulfide-releasing hybrid: A new class of anti-inflammatory pharmaceuticals R Kodela, M Chattopadhyay, K Kashfi ACS medicinal chemistry letters 3 (3), 257-262, 2012 | 197 | 2012 |
Ovariectomized rat model of osteoporosis: a practical guide N Yousefzadeh, K Kashfi, S Jeddi, A Ghasemi EXCLI journal 19, 89, 2020 | 191 | 2020 |
Resolution of inflammation: An organizing principle in biology and medicine D Panigrahy, MM Gilligan, CN Serhan, K Kashfi Pharmacology & therapeutics 227, 107879, 2021 | 170 | 2021 |
Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin–TCF association N Nath, K Kashfi, J Chen, B Rigas Proceedings of the National Academy of Sciences 100 (22), 12584-12589, 2003 | 168 | 2003 |
The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells C Bortuzzo, R Hanif, K Kashfi, L Staiano-Coico, SJ Shiff, B Rigas Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 1300 (3 …, 1996 | 168 | 1996 |
Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics BD Paul, SH Snyder, K Kashfi Redox Biology 38, 101772, 2021 | 154 | 2021 |
Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect M Chattopadhyay, R Kodela, N Nath, YM Dastagirzada, ... Biochemical pharmacology 83 (6), 715-722, 2012 | 154 | 2012 |
Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and β-catenin/T-cell factor signaling, nuclear … JL Williams, N Nath, J Chen, TR Hundley, J Gao, L Kopelovich, K Kashfi, ... Cancer research 63 (22), 7613-7618, 2003 | 152 | 2003 |
NOSH–aspirin (NBS-1120), a novel nitric oxide-and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model M Chattopadhyay, R Kodela, KR Olson, K Kashfi Biochemical and biophysical research communications 419 (3), 523-528, 2012 | 142 | 2012 |
Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention K Kashfi, B Rigas Biochemical pharmacology 70 (7), 969-986, 2005 | 122 | 2005 |
Insulin regulates enzyme activity, malonyl-CoA sensitivity and mRNA abundance of hepatic carnitine palmitoyltransferase-I EA Park, RL Mynatt, GA Cook, K Kashfi Biochemical Journal 310 (3), 853-858, 1995 | 120 | 1995 |
NO-donating aspirin inhibits intestinal carcinogenesis in Min (APCMin/+) mice JL Williams, K Kashfi, N Ouyang, P del Soldato, L Kopelovich, B Rigas Biochemical and biophysical research communications 313 (3), 784-788, 2004 | 116 | 2004 |
Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo M Chattopadhyay, R Kodela, N Nath, A Barsegian, D Boring, K Kashfi Biochemical pharmacology 83 (6), 723-732, 2012 | 112 | 2012 |
Regulation of vascular tone homeostasis by NO and H2S: Implications in hypertension S Gheibi, S Jeddi, K Kashfi, A Ghasemi Biochemical pharmacology 149, 42-59, 2018 | 107 | 2018 |
Anti-inflammatory agents as cancer therapeutics K Kashfi Advances in pharmacology 57, 31-89, 2009 | 107 | 2009 |